Karen Wilson - Jun 9, 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Karen J. Wilson
Stock symbol
ELTX
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 05:26 PM
Previous filing
Jun 17, 2021
Next filing
Dec 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Common Stock Award $0 +15K $0.00 15K Jun 9, 2022 Common Stock 15K $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.